The global Medical Foods for Inborn Errors of Metabolism size was valued at USD 3.12 billion in 2024 and is projected to reach USD 9.14 billion by 2032, with a CAGR of 14.39 % during the forecast period of 2025 to 2032. The global business landscape is undergoing a transformation, with industries increasingly leaning on deep research and actionable insights to make strategic decisions. One...